全文获取类型
收费全文 | 67699篇 |
免费 | 6137篇 |
国内免费 | 1234篇 |
专业分类
耳鼻咽喉 | 569篇 |
儿科学 | 1486篇 |
妇产科学 | 659篇 |
基础医学 | 3445篇 |
口腔科学 | 932篇 |
临床医学 | 10391篇 |
内科学 | 5726篇 |
皮肤病学 | 364篇 |
神经病学 | 2368篇 |
特种医学 | 11408篇 |
外国民族医学 | 60篇 |
外科学 | 6324篇 |
综合类 | 9346篇 |
现状与发展 | 1篇 |
一般理论 | 1篇 |
预防医学 | 5074篇 |
眼科学 | 482篇 |
药学 | 4082篇 |
26篇 | |
中国医学 | 1188篇 |
肿瘤学 | 11138篇 |
出版年
2024年 | 106篇 |
2023年 | 1057篇 |
2022年 | 1564篇 |
2021年 | 3059篇 |
2020年 | 2475篇 |
2019年 | 2149篇 |
2018年 | 2079篇 |
2017年 | 2088篇 |
2016年 | 2329篇 |
2015年 | 2325篇 |
2014年 | 4677篇 |
2013年 | 4347篇 |
2012年 | 4468篇 |
2011年 | 4994篇 |
2010年 | 4245篇 |
2009年 | 3928篇 |
2008年 | 3823篇 |
2007年 | 3892篇 |
2006年 | 3484篇 |
2005年 | 3029篇 |
2004年 | 2399篇 |
2003年 | 1785篇 |
2002年 | 1410篇 |
2001年 | 1248篇 |
2000年 | 1061篇 |
1999年 | 816篇 |
1998年 | 766篇 |
1997年 | 630篇 |
1996年 | 555篇 |
1995年 | 535篇 |
1994年 | 442篇 |
1993年 | 355篇 |
1992年 | 328篇 |
1991年 | 295篇 |
1990年 | 233篇 |
1989年 | 229篇 |
1988年 | 202篇 |
1987年 | 165篇 |
1986年 | 145篇 |
1985年 | 210篇 |
1984年 | 218篇 |
1983年 | 178篇 |
1982年 | 192篇 |
1981年 | 113篇 |
1980年 | 102篇 |
1979年 | 92篇 |
1978年 | 51篇 |
1977年 | 60篇 |
1976年 | 53篇 |
1974年 | 19篇 |
排序方式: 共有10000条查询结果,搜索用时 187 毫秒
1.
This meta-analysis was designed to assess the effectiveness and safety of extracorporeal shock wave therapy (ESWT) for patients with low back pain (LBP). Pubmed, Embase, Cochrane's library, PEDro (Physiotherapy Evidence Database), China National Knowledge Infrastructure (CNKI), and Wanfang Data were searched until December 2019 to identify studies assessing the effectiveness and safety of EPSW for LBP. The prime outcome is pain intensity measured by Visual Analog Scale (VAS) or numeric rating scale (NRS). Other outcomes included functional status, quality of life, psychological outcomes measured by Oswestry Disability Index (ODI), as well as the adverse events. Mean differences (MD) were calculated for continuous outcomes, while odd ratios (OR) were calculated for binary outcomes. Revman 5.3 software was used for statistical analysis. Five randomized controlled trials (RCTs) were finally included in this meta-analysis. The pooled mean difference in post-treatment pain scores was −2.37 (P <0.0001), indicating that post-treatment pain scores was significantly higher by 2.37 in control group than in ESWT group. At a mean follow-up time of 4–6 weeks, the pooled mean difference in ODI scores was −14.10 (P <0.00001), indicating that the pooled mean difference of post-treatment ODI scores was 14.10 higher in control group than in ESWT group. The use of ESWT is effective in alleviating pain and improving the general functional state for patients with LBP. However, more evidence was needed to verify its safety. 相似文献
2.
3.
4.
《Journal of infection and chemotherapy》2022,28(4):548-553
IntroductionCOVID-19 patients have been reported to have digestive symptoms with poor outcome. Ivermectin, an antiparasitic drug, has been used in COVID-19 patients. The objective of this study was to evaluate whether ivermectin has effects on gastrointestinal complications and ventilator-free days in ventilated patients with COVID-19.MethodsCOVID-19 patients who were mechanically ventilated in the ICU were included in this study. The ventilated patients who received ivermectin within 3 days after admission were assigned to the Ivermectin group, and the others were assigned to the Control group. Patients in the Ivermectin group received ivermectin 200 μg/kg via nasal tube. The incidence of gastrointestinal complications and ventilator-free days within 4 weeks from admission were evaluated as clinical outcomes using a propensity score with the inverse probability weighting method.ResultsWe included 88 patients in this study, of whom 39 patients were classified into the Ivermectin group, and 49 patients were classified into the Control group. The hazard ratio for gastrointestinal complications in the Ivermectin group as compared with the Control group was 0.221 (95% confidence interval [CI], 0.057 to 0.855; p = 0.029) in a Cox proportional-hazard regression model. The odds ratio for ventilator-free days as compared with the Control group was 1.920 (95% CI, 1.076 to 3.425; p = 0.027) in a proportional odds logistic regression model.ConclusionsIvermectin improved gastrointestinal complications and the number of ventilator-free days in severe COVID-19 patients undergoing mechanical ventilation. Prevention of gastrointestinal symptoms by SARS-Cov-2 might be associated with COVID-19 outcome. 相似文献
5.
6.
Adjuvant irradiation is the standard treatment after breast conservative surgery. Normofractionated regimen with an overall treatment time of 5 to 6 weeks is often considered as a limiting factor for irradiation compliance. In order to answer this issue, moderate and more recently extreme hypofractionated protocols appeared. We report here oncological outcomes and toxicity of hypofractionated breast irradiation. After defining the frame of moderate and extreme hypofractionated breast irradiations based on overall treatment time, patient selection criteria were listed. According to their levels of proof, the results of moderate and extreme hypofractionated breast irradiation were analysed. Overall treatment time for moderate hypofractionated breast irradiation ranged from 3 to 4 weeks, while for extreme hypofractionated breast irradiation, it was less than 1 week. For moderate hypofractionated breast irradiation, whole breast irradiation was currently performed with or without lymph node irradiation. Moderate hypofractionated breast irradiation has proven to be as safe and as efficient as normofractionated breast irradiation with level IA evidence. For extreme hypofractionated breast irradiation, phase III randomized trials confirmed that accelerated partial breast irradiation was non-inferior in terms of local control compared to normofractionated whole breast irradiation (with external beam radiation therapy and multicatheter brachytherapy), with similar acute and late toxicity. While the use of intraoperative breast irradiation remains under debate, new very accelerated partial breast irradiation (overall treatment time not exceeding 2 days) protocols emerged with encouraging results. Accelerated partial breast irradiation is warranted for extreme hypofractionated breast irradiation and is indicated for low-risk breast cancers. Moderate and extreme hypofractionated breast irradiation regimens are validated and can be routinely proposed according to patient selection criteria. 相似文献
7.
8.
Place et modalités de l’irradiation postopératoire dans la prise en charge des métastases cérébrales
《Cancer radiothérapie》2020,24(6-7):477-481
Metastases are the most common brain tumors. After surgery, stereotactic radiotherapy (SRT) of the resection cavity is the standard of care. Data from two randomized trials indicate that SRT to the surgical bed is an effective treatment in reducing local failure as compared with observation, while reducing the risk of cognitive deterioration and maintaining quality of life as compared with whole brain radiation therapy. Local control appears higher after hypofractionated SRT compared to single-fraction SRT. Several questions such as target volumes, the optimal regimen in particular for large tumor bed, strategies to reduce the risk of lepto-meningeal recurrence, and the treatment sequence still need to be answered. 相似文献
9.
《中国现代医生》2020,58(9):144-146+封三
目的探讨MSCT在对比剂外渗的急性腹部创伤性动脉损伤诊断中的应用价值。方法回顾性分析本院2016年1月~2018年12月收治的44例急性创伤性腹部动脉损伤患者及58例腹部非创伤性动脉病变患者影像资料,分析急性腹部创伤性和非创伤性动脉病变所致对比剂外渗的相关性。结果 44例创伤性腹部损伤患者通过MSCT及图像后处理技术共检出59支动脉损伤,其中对比剂外渗34支、非对比剂外渗共25支;58例急性腹部非创伤组共检出58支动脉病变,其中8支存在对比剂外渗。对比剂外渗征象创伤组出现率明显高于非创伤性组(χ~2=24.42,P0.05)。结论与非创伤组相比,急性腹部创伤性动脉损伤对比剂外渗征象较为常见,MSCT可以较好地显示创伤性对比剂外渗的直接及间接征象。 相似文献
10.